Printer Friendly

ADAP (AIDS Drug Assistance Program) Funding: Action Needed.

Almost half of all states have already indicated that they may have to restrict their AIDS Drug Assistance Program by the end of 2001. Restrictions can include waiting lists, caps on services, cutting drugs off the formulary, or even closing the program to new enrollment because money is low. Additional states may be affected as well.

Recently we learned that California is looking at its program to decide what drugs to remove from its program if necessary.

The basic problem is that federal and state funding has not kept up with the greater number of patients who need treatment, since people today are living longer. The new guidelines that call for starting treatment somewhat later will help to balance expenses, but is not enough to make up the difference.

On June 14 Project Inform's Treatment Action Network sent out an alert listing some of the states soon to be affected:

In the last appropriations bill, ADAP received $60 million less than projected as needed to provide standard of care for its clients. In addition, the number of new clients and the costs of drugs continue to rise, putting an additional strain on many state ADAPs. Many programs are expected to face serious problems in the next few months without an emergency supplemental. According to a recent report by the National Alliance of State and Territorial AIDS Directors (NASTAD), nearly half of all states have indicated that they might have to place emergency restrictions on their programs this year, such as implementing or expanding waiting lists, capping services, and/or making cuts to the list of available drugs. Currently, there are ADAP waiting lists in Alabama, Arkansas, Georgia, Indiana, Kentucky, Maine, Montana, Oklahoma, South Carolina, and South Dakota. Even states with the most comprehensive ADAPs such as California, New York, and Pennsylvania are expected to feel the effects of the budget shortfall.

That action alert asked recipients to call or email President Bush, and their two U.S. Senators (you can find contact information for Senators from their Web sites, which can be reached through http://www.senate.gov).

What You Can Do

The ADAP situation is changing daily. To be informed how you can help on this and other treatment and access issues, you can join Project Inform's Treatment Action Network. Send an email to tan@projectinform.org, and ask to receive their action alerts.
COPYRIGHT 2001 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:AIDS Treatment News
Geographic Code:1USA
Date:Jun 23, 2001
Words:395
Previous Article:Mitochondrial Toxicity: Report on the Web.
Next Article:AIDS Vaccines and Activism: Interview with Jon Cohen.
Topics:


Related Articles
Drug Pricing.
ADAP and Medicaid financial emergencies growing.
T-20: most expensive AIDS drug ever at $25,000 per year?
Abbott Laboratories increases Norvir price fivefold.
Ban cross border pharmacies, protect price regulation system, groups urge.
New Medicare-approved prescription drug discount card.
Medicare HIV fact sheet: caution re January 2006.
Got Medicare? What people living with HIV need to know about the new medicare drug benefit--"Part D"--starting January 1st, 2006.
Medicare prescription nightmare: overview January 28, 2006.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters